Calyxt Inc (NASDAQ:CLXT) insider Daniel F. Voytas sold 4,083 shares of Calyxt stock in a transaction that occurred on Monday, September 10th. The stock was sold at an average price of $16.13, for a total value of $65,858.79. The sale was disclosed in a filing with the SEC, which is available at this link.

Daniel F. Voytas also recently made the following trade(s):

  • On Monday, August 20th, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The stock was sold at an average price of $17.31, for a total value of $80,768.46.
  • On Wednesday, August 8th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The stock was sold at an average price of $17.48, for a total value of $71,370.84.
  • On Monday, July 9th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The stock was sold at an average price of $17.84, for a total value of $72,840.72.
  • On Wednesday, June 20th, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The stock was sold at an average price of $20.56, for a total value of $95,932.96.
  • On Friday, June 15th, Daniel F. Voytas sold 7,539 shares of Calyxt stock. The stock was sold at an average price of $19.49, for a total value of $146,935.11.

NASDAQ:CLXT opened at $16.05 on Friday. The company has a market cap of $516.57 million, a P/E ratio of -14.33 and a beta of 3.47. The company has a quick ratio of 21.27, a current ratio of 21.27 and a debt-to-equity ratio of 0.16. Calyxt Inc has a 1-year low of $13.09 and a 1-year high of $31.89.

Calyxt (NASDAQ:CLXT) last released its quarterly earnings results on Wednesday, August 1st. The company reported ($0.25) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.03). The firm had revenue of $0.20 million for the quarter, compared to analyst estimates of $0.10 million. Calyxt had a negative return on equity of 45.34% and a negative net margin of 7,253.78%. equities research analysts forecast that Calyxt Inc will post -1.02 earnings per share for the current year.

Several research analysts have recently commented on the company. Goldman Sachs Group assumed coverage on Calyxt in a research note on Friday, September 7th. They set a “neutral” rating and a $18.00 target price for the company. ValuEngine upgraded Calyxt from a “hold” rating to a “buy” rating in a research note on Friday, July 20th. Jefferies Financial Group reiterated a “buy” rating and set a $27.00 target price on shares of Calyxt in a research note on Friday, June 22nd. Finally, Zacks Investment Research upgraded Calyxt from a “hold” rating to a “buy” rating and set a $19.00 target price for the company in a research note on Monday, May 28th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $26.04.

Large investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC lifted its holdings in Calyxt by 134.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,583 shares of the company’s stock worth $123,000 after purchasing an additional 3,781 shares during the last quarter. PNC Financial Services Group Inc. acquired a new stake in Calyxt during the 2nd quarter worth approximately $186,000. California Public Employees Retirement System acquired a new stake in Calyxt during the 2nd quarter worth approximately $187,000. Granite Investment Partners LLC acquired a new stake in Calyxt during the 2nd quarter worth approximately $216,000. Finally, Citadel Advisors LLC acquired a new stake in Calyxt during the 2nd quarter worth approximately $342,000. 28.07% of the stock is owned by institutional investors and hedge funds.

About Calyxt

Calyxt, Inc is a consumer-centric, food and agriculture focused company. It engages in the development of specialty food ingredients, such as healthier oils, high fiber wheat, and food crops with desirable traits, such as herbicide tolerance. The company provides healthier food ingredients for consumers and agriculturally advantageous traits for farmers.

Recommended Story: Earnings Per Share

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.